Verici Dx Plc (GB:VRCI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Verici Dx Plc has announced the successful completion of a urine sample transfer to Thermo Fisher Scientific, a step in the global commercialization and licensing agreement from November 2023. The company, specializing in advanced diagnostics for organ transplant, has received full payment for the transfer, underscoring the value of its data and sample assets for research. CEO Sara Barrington expressed satisfaction with the company’s adherence to timelines and the demonstration of its commitment to agreements.
For further insights into GB:VRCI stock, check out TipRanks’ Stock Analysis page.